Clinical trial of medication to treat NF2 tumors starting soon

More info…
Researchers are recruiting patients for a Phase II clinical trial to test a medication that may slow the progression of Neurofibromatosis Type-2, commonly referred to as NF2.

Be Sociable, Share!

Leave a Reply